Skip to content

Clinical study of All-in-One one-stop radiotherapy for rectal cancer based on uRT-linac 506c and automatic target segmentation modeling

Clinical study of All-in-One one-stop radiotherapy for rectal cancer based on uRT-linac 506c and automatic target segmentation modeling

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500106227
Enrollment
Unknown
Registered
2025-07-21
Start date
2024-09-19
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal cancer

Interventions

Rectal cancer group:None

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients with rectal cancer aged 18-80 years 2.Scheduled to receive radiation therapy at the Department of Radiotherapy for Tumors, Peking University Third Hospital 3. The investigator determines the general health status of the subject based on the subject's medical history, physical examination, vital signs

Exclusion criteria

Exclusion criteria: 1.Patients who, in the opinion of the investigator, are not suitable to participate in this clinical study 2.The subject has no history of diseases associated with renal hemodynamic stability, including, but not limited to, asymptomatic congestive heart failure, uncontrolled hypertension, unstable angina pectoris, cardiac arrhythmias, active peptic ulcer, or bleeding disorders.

Design outcomes

Primary

MeasureTime frame
Target volume delineation time cost;Total time cost;Plan optimization time cost;

Secondary

MeasureTime frame
OARs delineation time cost;

Countries

China

Contacts

Public ContactWang Hao

Peking University Third Hospital

hhbysy@126.com+86 186 1120 7267

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026